Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update.

Giorgino R, Albano D, Fusco S, Peretti GM, Mangiavini L, Messina C. · 2023

Read Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update. by Giorgino R, Albano D, Fusco S, Peretti GM, Mangiavini L, Messina C. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10094836.txt.

Introduction

Giorgino and colleagues review knee osteoarthritis in a 2023 update, covering its spread, causes, and the role of stem cells. Osteoarthritis is the most common joint disease, and the knee bears much of its burden. Rates vary widely between studies and places, which the authors work to explain.

The review describes how cartilage breaks down and pain develops over time. It surveys standard care, from exercise and weight control to surgery. It then assesses what mesenchymal stem cells can and cannot yet offer. The update is a practical guide for clinicians.

Catalog record

CREATORGiorgino R, Albano D, Fusco S, Peretti GM, Mangiavini L, Messina C.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10094836

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update By Riccardo Giorgino, Domenico Albano, Stefano Fusco, Giuseppe M. Peretti, Laura Mangiavini, Carmelo Messina, Walter Herzog Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms24076405 ABSTRACT Osteoarthritis (OA) is a chronic disease and the most common orthopedic disorder. A vast majority of the social OA burden is related to hips and knees. The prevalence of knee OA varied across studies and such differences are reflected by the heterogeneity of data reported by studies conducted worldwide. A complete understanding of the pathogenetic mechanisms underlying this pathology is essential. The OA inflammatory process starts in the synovial membrane with the activation of the immune system, involving both humoral and cellular mediators. A crucial role in this process is played by the so-called “damage-associated molecular patterns” (DAMPs). Mesenchymal stem cells (MSCs) may be a promising option among all possible therapeutic options. However, many issues are still debated, such as the best cell source, their nature, and the right amount. Further studies are needed to clarify the remaining doubts. This review provides an overview of the most recent and relevant data on the molecular mechanism of cartilage damage in knee OA, including current therapeutic approaches in regenerative medicine. 1. INTRODUCTION Osteoarthritis (OA) is a chronic disease affecting the joint and its tissues, primarily leading to progressive damage to articular cartilage and, subsequently, to the subchondral bone and surrounding synovial structures [1]. OA is a disabling condition with increasing incidence and prevalence in the general population. As one of the most common orthopedic conditions, it is associated with a high health burden and implications not only for affected patients but also for healthcare systems [2]. Different joints can be involved, yet most social OA burdens are related to hip and knee OA, both cause progressive disability and possibly lead to prosthesis replacements. Worldwide it has been recently estimated that there is an overall prevalence of about 300 million for hip and knee OA [3]. A report from the Global Burden of Disease in 2010 explored the burden of hip and knee OA comparing both conditions with other diseases [4]. According to this report, hip and knee OA represent one of the leading causes of global disability. The disease impact is measured by means of years lived with disabilities (YLDs) and disability-adjusted life years (DALYs) estimates. At a worldwide level and according to YLDs measurements, hip and knee OA is ranked as the 11th highest contributor to global disability [4]. YLDs for hip and knee OA increased from 10.5 million in 1990 to 17.1 million in 2010. Regarding disease disability, for all ages, DALYs for hip/knee OA rose from 0.42% (total DALYs in 1990) to 0.69% in 2010 [4]. Osteoarthritis is a chronic disease with multifactorial pathogenesis frequently associated with other comorbidities; therefore, disease prevention and early-stage treatment may not be easy [5]. The epidemiology and pathogenesis of hip and knee OA have been studied more extensively than other joints, and increasing interest has been devoted to the study of those molecular mechanisms, which led to cartilage damage due to their pivotal role in the pathogenesis of OA. The most frequently associated risk factors for knee OA are aging, genetic predisposition, and obesity. The instrumental diagnosis of OA is commonly performed using conventional radiography, which can complement clinical examinations despite not always being needed for the first-line diagnosis [6]. Typically, the severity of OA in X-rays is evaluated using the Kellgren and Lawrence scale, a semi-quantitative scoring system from 0 to 4 [7]. Computed tomography (CT) and magnetic resonance imaging (MRI) represent second-line techniques, with MRI being capable of providing a full assessment of the joint (cartilage, subchondral bone, bone marrow, soft tissue structure, and inflammation status) [8]. Therefore, although MRI is an expensive examination, it has several advantages for early diagnosis of OA and research purposes [9]. Conversely, the role of ultrasound is mainly limited to soft tissue and inflammation evaluations [6]. For an early diagnosis, we report the promising use of vibroarthrography as a diagnostic tool that records vibrations caused by the joint through local accelerometers on the skin [10,11]. This technique, proposed in the literature as a safe, noninvasive, inexpensive, and reproducible tool, has demonstrated high diagnostic accuracy in the analysis of cartilage lesions [12,13,14]. This review proposes an overview of recent studies focusing on OA epidemiology, pathogenesis, and treatment. In particular, this paper will focus on the molecular mechanism in joint damage, including the most recent evidence on those mechanisms and mediators of the OA inflammatory response. Another topic in this review will be the field of regenerative medicine, in which we will discuss the most recent therapeutic approaches related to the use of mesenchymal stem cells. 2. MATERIALS AND METHODS Two authors (R.G. and C.M.) independently performed the literature search. The last update to the search was conducted in January 2023 and accessed PubMed, Google Scholar, Embase, and Scopus. The following keywords were used in combination with the Boolean operator AND/OR: knee osteoarthritis AND MSCs OR mesenchymal stem cells OR epidemiology OR mechanism OR pathophysiology OR pathogenesis. No additional filters or time constraints were used for the search. The same authors independently screened the resulting articles. If the title and abstract matched the topic, the full-text article was accessed. A cross reference of the bibliographies was also performed. Disagreements were debated and solved by a third author (L.M.). 3. KNEE OSTEOARTHRITIS: RECENT TRENDS ABOUT EPIDEMIOLOGY AND RISK FACTORS The prevalence of knee OA varied across studies according to its definition, diagnostic method, and range of age included. Such differences are reflected by the heterogeneity of data reported by studies conducted worldwide. A recent meta-analysis conducted in China investigated the prevalence of knee OA in symptomatic patients by including 21 studies for an overall number of 74,908 subjects [15]. The overall prevalence of OA was reported to be 14.6% from studies performed in a period ranging from 2012 to 2016. Females presented with a higher knee OA prevalence than males (19.1% vs. 10.9%, respectively). The prevalence also increased with age. A demographic study from the Korean National Health and Nutrition Examination Survey (KNHANES) analyzed the prevalence of radiographic OA from 12,287 subjects older than 50 years and found it to be 35.1% [16]. Again, women were at higher risk of developing knee OA than men. Data from the Chingford Study in the United Kingdom showed that over 5 years the incidence of radiographic knee OA was 17.6% in women with ages ranging from age 45 to 64 years [17]. A study from the United States (US) estimated the incidence of symptomatic knee OA (OA) with the use of self-reported population-based data, reporting that approximately 9.29% of subjects older than 60 years presented a diagnosis of symptomatic knee OA [18]. Moreover, the overall estimated lifetime risk was reported to be 13.83%. Although OA is not an unavoidable consequence of aging, extensive evidence confirms age as the single major risk factor for the development of OA, especially in weight-bearing joints such as hips and knees [19]. This finding has clearly emerged from several radiographic studies, which showed typical radiographic changes (joint space narrowing and osteophytosis) being very common in the

Read the complete text